Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Aviron's intranasal influenza vaccine begins phase III

Aug. 30, 1996

FDA approval requested for thymoglobin manufacturing process, facility

Aug. 30, 1996

STV: Possible antituberculosis and autoimmune disease therapy

Aug. 23, 1996

Immunomodulating peptides from BioChem Pharma

Aug. 23, 1996

Cel-Sci and U.S. Navy collaborate on malaria vaccine

Aug. 23, 1996

North American Vaccine/Abbott DTaP marketing agreement

Aug. 23, 1996

Acellular antiBortedella vaccine claimed by Institut Pasteur

Aug. 16, 1996

Oxygermylpropionic acid polymer reported by Sanwa Kagaku

Aug. 16, 1996

FDA approves expanded use of Acel-Imune

Aug. 16, 1996

CSL discloses HPV vaccine components

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.